2011 annual financial data
Bone Biologics 2011 Operating cash flow growth
Direct answer
Operating cash flow growth was 87.5%.
Operating income was -3,000 USD and net income was Not available.
Operating cash flow was -5,681 USD.
Get free Bone Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -3,000 USD
- Net income
- Not available
- Operating cash flow
- -5,681 USD